Journals / Türk Kardiyoloji Derneği Arşivi / 2019 / Cilt: 47 - Sayı: 7

The impact of the new World Symposium on Pulmonary Hypertension definition of pulmonary hypertension on the prevalence of pre-capillary pulmonary hypertension

Dünya Pulmoner Hipertansiyon Kongresi yeni pulmoner hipertansiyon tanımlamasının pre-kapiller pulmoner hipertansiyon prevalansına etkisi

Pages
594–598
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Forty-three of 58 patients (74.1%) were classified as pre-capillary PH according to the ESC/ERS PH guideline, whereas 50 of 58 patients (86.2%) had pre-capillary PH according to the new WSPH definition.Conclusion: The results of this study indicated that the impact of the new definition of PH on the number of pre-capillary PH patients identified was greater than the predicted

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Since the first World Symposium on Pulmonary Hypertension (WSPH; Geneva, 1973), pulmonary hypertension (PH) has been defined as a mean pulmonary artery pressure (mPAP) ≥25 mm Hg measured at right heart catheterization (RHC) while at rest in the supine position.
📊
Key Findings & Data:At the 6th WSPH congress (Nice, 2018), a new proposal was presented defining pre-capillary PH as mPAP >20 mm Hg,with pulmonary arterial wedge pressure (PAWP) 3 WU.
💡
Conclusion & Impact:Forty-three of 58 patients (74.1%) were classified as pre-capillary PH according to the ESC/ERS PH guideline, whereas 50 of 58 patients (86.2%) had pre-capillary PH according to the new WSPH definition.Conclusion: The results of this study indicated that the impact of the new definition of PH on the number of pre-capillary PH patients identified was greater than the predicted
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Since the first World Symposium on Pulmonary Hypertension (WSPH; Geneva, 1973), pulmonary hypertension (PH) has been defined as a mean pulmonary artery pressure (mPAP) ≥25 mm Hg measured at right heart catheterization (RHC) while at rest in the supine position. At the 6th WSPH congress (Nice, 2018), a new proposal was presented defining pre-capillary PH as mPAP >20 mm Hg,with pulmonary arterial wedge pressure (PAWP) 3 WU. The aim of this study was to investigate the impact of the newdefinition of PH on the number of pre-capillary PH patients.Methods: The results of RHC performed with various clinical indications between 2017 and 2018 were analyzed. The 2015 European Society of Cardiology (ESC)/European Respiratory Society (ERS) and the 6th WSPH congress PH definitions were used to identify PH patients.Results: Fifty-eight RHC procedures were performed in our hospital in a 1-year period. Most were performed with a suspicion of PH (n=52). The remainder (n=6) were performed with indications of valvular heart disease or left heart disease. There were 40 females (69%) and 18 males (31%). The mean age was 53.3±16.6 years. The RHC results revealed a mean PAP of 36.4±16.4 mm Hg, PAWP of 12.6±3.9 mm Hg, and PVR of 4.9±4.4 WU. Forty-three of 58 patients (74.1%) were classified as pre-capillary PH according to the ESC/ERS PH guideline, whereas 50 of 58 patients (86.2%) had pre-capillary PH according to the new WSPH definition.Conclusion: The results of this study indicated that the impact of the new definition of PH on the number of pre-capillary PH patients identified was greater than the predicted

Özet

Amaç: 1. Dünya Pulmoner Hipertansiyon Kongresi’nde (Genova, 1973) pulmoner hipertansiyon (PH), sağ kalp katateri ile istirahatte supin pozisyonunda ölçülen ortalama pulmoner arter basıncının (PAB) ≥25 mm Hg olması olarak tanımlandı. Bu sene düzenlenen 6. Dünya Pulmoner Hipertansiyon Kongresi’nde (Nice, 2018) ise bu tanımın, ortalama PAB >20 mm Hg, pulmoner kapiller uç basıncı (PKUB) 3 WU olarak güncellenmesi önerildi. Bu çalışmada, yeni tanımlamayla birlikte pre-kapiller PH hasta sayımızdaki artış miktarını araştırmayı amaçladık.Yöntemler: 2017–2018 yılları arasında, hastanemizde çeşitli endikasyonlarla yapılan sağ kalp kateteri raporları tarandı. Hem 2015 Avrupa Kardiyoloji ve Solunum Derneği (ESC/ERS) hem de 6. Dünya Pulmoner Hipertansiyon Kongresi PH tanı kriterleri kullanılarak, PH tanısı alan hasta sayısı (%) hesaplandı. Bulgular: Bir yıllık periyotta hastanemizde 58 hastaya sağ kalp katateri uygulandı. İşlemlerin çoğunluğu PH ayırıcı tanısı endikasyonuyla (n=52) uygulandı. Diğer endikasyonlar arasında kalp kapak hastalığı ve sol kalp hastalıkları yer almaktaydı (n=6). Hastaların 40’ı kadın (%69), 18’i erkek (%31) hastalardan oluşmaktaydı. Çalışma grubunun ortalama yaşı 53.3±16.6 idi. Sağ kalp kataterinde ortalama PAB 36.4±16.4 mm Hg, ortalama PKUB: 12.6±3.9 ve ortalama PVR: 4.9±4.4 WU olarak saptandı. 2015 ESC ve ERS PH kılavuz tanı kriterlerine göre PH tanısı alan hasta sayısı 43/58 (%74.1) iken, bu oran 6. Dünya Pulmoner Hipertansiyon Kongresi PH tanı kriterlerine göre 50/58 (%86.2) olarak saptandı.Sonuç: 6. Dünya PH Kongresinde yeni hemodinamik prekapiller PH tanımlamasıyla hasta sayısındaki artışın

🔖

Cite This Article

ÖZKAN, A. A., KÜÇÜKOĞLU, M. S., ERSANLI, M. K., ÇETİNARSLAN, Ö., SİNAN, Ü. Y. (2022). The impact of the new World Symposium on Pulmonary Hypertension definition of pulmonary hypertension on the prevalence of pre-capillary pulmonary hypertension. Türk Kardiyoloji Derneği Arşivi, Cilt: 47 - Sayı: 7, 594–598. https://ajindex.com/articles/632032

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016;37:67–119
  2. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 2004;351:1655–65
  3. Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 2009;34:888–94 4. Galie N, McLaughlin VV, Rubin LJ, Simmonneau G. An overview of the 6th World Symposium on Pulmonary Hypertension. Eur Respir J 2018
  4. Simmonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2018
  5. Valerio CJ, Schreiber BE, Handler CE, Denton CP, Coghlan JG. Borderline mean pulmonary artery pressure in patients with systemic sclerosis: trans-pulmonary gradient predicts risk of developing pulmonary hypertension. Arthritis and Rheumatism 2013;65:1074–84
  6. Coghlan JG, Wolf M, Distler O, Denton CP, Doelberg M, Harutyunova S, et al. Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis. Eur Respir J 2018;51:pii:1701197 8. Douschan P, Kovacs G, Avian A, Foris V, Gruber F, Olschewski A, et al. Mild Elevation of Pulmonary Arterial Pressure as a Predictor of Mortality. Am J Respir Crit Care Med 2018;197:509–16
  7. Taboada D, Pepke-Zaba J, Jenkins DP, Berman M, Treacy CM, Cannon JE, et al. Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease. Eur Respir J 2014;44:1635–45
  8. Badesch DB, Raskob GE, Elliot G, Krichmann AM, Farber HW, Frost AE, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest 2010;137:376–87
  9. Hoeper MM, Huscher D, Ghofrani HA, Delcroix M, Distler O, Schweiger C, et al. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry. Int J Cardiol 2013;168:871–80
  10. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, et al. Pulmonary arterial hypertension in France: results from a national re